Related Experiment Video
Updated: Jul 15, 2026
06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Diagnosing prostate cancer - what GPs need to know
Mark Frydenberg1, Sanjiva Wijesinha
1Department of Urology, Monash Medical Centre, Monash University, Victoria, Australia.
Australian Family Physician
|May 12, 2007
Summary
Early prostate cancer detection is crucial for better outcomes. General practitioners play a key role in identifying at-risk men using prostate-specific antigen (PSA) tests and digital rectal exams.
Area of Science:
- Oncology
- Urology
- General Practice
Background:
- Prostate cancer often presents with symptoms only at advanced, incurable stages.
- Early diagnosis by general practitioners is vital for effective management.
- General practitioners require updated knowledge on prostate cancer detection and patient advice.
Purpose of the Study:
- To present the latest information on the natural history of prostate cancer.
- To outline current methods for detecting prostate cancer in Australian men.
Main Methods:
- Review of current medical literature on prostate cancer.
- Focus on diagnostic tools and risk assessment.
Main Results:
- Prostate cancer is frequently asymptomatic in early stages.
- Lower urinary tract symptoms (LUTS) are more indicative of benign prostate conditions.
- Approximately 20% of men with prostate cancer have a normal prostate-specific antigen (PSA) level.
Conclusions:
- Early prostate cancer detection relies on both PSA testing and digital rectal examination.
- Population-wide screening is not currently recommended.
- Targeted 'case detection' for at-risk individuals is a common practice.
- Informed patient involvement is essential for successful case detection.
